trending Market Intelligence /marketintelligence/en/news-insights/trending/HBewi0PSRx8qI35lO-ANQg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Generation Bio closes $110M series C round

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Generation Bio closes $110M series C round

Generation Bio Co. secured $110 million in series C funding led by T. Rowe Price Group Inc. funds and accounts.

Farallon Capital Management LLC and Wellington Management Co. LLP also participated in the round, alongside existing backers Atlas Venture LP, Fidelity Management & Research Co., The Invus Group LLC, Casdin Capital LLC, Deerfield Management Co. LP, Foresite Capital Management LLC and an entity related to SVB Leerink LLC.

The gene therapy-focused biotechnology company will use the new capital to move its two liver-targeted programs for hemophilia A and phenylketonuria into investigational new drug-enabling studies and clinical development.

Cowen was the exclusive placement agent for the funding round.